Valproic acid: A viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures
- 2 May 2008
- journal article
- research article
- Published by Wiley in Biotechnology & Bioengineering
- Vol. 101 (1), 182-189
- https://doi.org/10.1002/bit.21882
Abstract
Various DNA methyl transferase inhibitors (iDNMTs) and histone deacetylase inhibitors (iHDACs) were screened for their ability to enhance transient gene expression (TGE) in Human Embryonic Kidney 293‐EBNA (HEK293E) cells. The effects in HEK293E cells were compared to those in Chinese Hamster Ovary DG44 (CHO‐DG44) cells. The iDNMTs and iHDACs were chosen based on their different cellular activities and mechanisms of action. For each inhibitor tested, the optimum concentration was determined for both cell lines, and these conditions were used to evaluate the effect of each compound using a recombinant monoclonal antibody as a reporter protein. All the iHDACs increased transient antibody yield at least 4‐fold in HEK293E and at least 1.5‐fold in CHO‐DG44. By comparison, the iDNMTs increased antibody yields by a maximum of ∼2‐fold. Pairwise combinations of iDNMTs and iHDACs had a linearly additive effect on TGE in CHO‐DG44 but not in HEK293E. With valproic acid (VPA), volumetric and specific productivities of 200 mg/L and 20 pg/cell/day, respectively, were achieved in HEK293E cells with a 10‐day process. As VPA is both FDA‐approved and 5‐fold less expensive than sodium butyrate (NaBut), we recommend it as a cost‐effective alternative to this widely used enhancer of recombinant protein production from mammalian cells. Biotechnol. Biotechnol. Bioeng. 2008;101: 182–189.Keywords
This publication has 30 references indexed in Scilit:
- High‐density transfection with HEK‐293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEIBiotechnology & Bioengineering, 2007
- Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectivesBiotechnology Letters, 2007
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005
- Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidineMolecular Cancer Therapeutics, 2005
- Activation of CMV promoter-controlled glycosyltransferase and β -galactosidase glycogenes by butyrate, tricostatin A, and 5-Aza-2′-deoxycytidineGlycoconjugate Journal, 2005
- Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivoGene Therapy, 2004
- TubeSpin satellites: a fast track approach for process development with animal cells using shaking technologyBiochemical Engineering Journal, 2004
- Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cellsThe EMBO Journal, 2001
- Methylation-Induced Repression— Belts, Braces, and ChromatinCell, 1999
- Expression of recombinant plasmids in mammalian cells Is enhanced by sodium butyrateNucleic Acids Research, 1983